CHEK1 and hepatocellular carcinoma: Moreover, in a TCGA cohort of 365 patients with HCC stratified by tertile cut-off values, patients with the highest levels of ATR or CHEK1 mRNA in their tumors exhibited the worst survival (Fig. 1H).